SAFETY
WIDELY USED.
TRUSTED FOR YEARS.
Lanluma is a CE-marked medical device, administered only by trained healthcare professionals.
2020
CE MARKED
Body and face applications in clinical use for over five years in markets where locally approved. Country-specific indications apply.
TRUSTED BY CLINICIANS
5+
YEARS OF REAL-WORLD DATA
Across Europe, LATAM, APAC, MENA. For diverse body types.
7
TREATMENT AREAS
Across face and body. Indications vary by country.
These figures describe clinical experience with the product and are not a measure of safety or effectiveness.
2×
AMWC AWARDS
Best Injectable Body Filler, 2023 & 2025.
HOW IT CLEARS
FULLY ABSORBED, OVER TIME.
Poly-L-lactic acid has an established medical history of more than 30 years. The body breaks it down and clears it completely over time — no residue remains. What stays is your own collagen.
WHAT TO EXPECT
DOWNTIME
Minimal. Mild swelling, redness, tenderness or bruising may occur for a few days. Avoid strenuous exercise, heat and sun for 24–48 hours.
Amselem M et al, J Cosmet Dermatol 2024 (post-market safety in neck, upper arm, hand, thigh, décolleté at 9 months). Always follow the aftercare advice of your treating practitioner.
-
Contraindications and Warnings: Refer to the full Instructions for Use for detailed information.
CONTRAINDICATION
LANLUMA is contraindicated in cases of
Patients under 18 years old.
Patients with known (Hyper) sensitivity to any of the product’s components.
Patients with active (or a history of) autoimmune disease.
Patients on current steroid treatment.
Patients undergoing immunosuppressive treatment.
Patients with active inflammation or infection.
Patients with skin diseases or skin disorders.
Patients with impaired wound healing caused by systemic disorders, medications or impaired vascularization.
Patients with bleeding disorders due to underlying medical conditions or as a side-effect of medications.
Patients with history of severe anaphylactic reactions.
Breast feeding or pregnant woman.
Injection in or near periorbital area, lips, nose or forehead.WARNING
This product should only be used in the deep dermis or in the subdermal regions (i.e., subcutaneously or supraperiosteally).
To prevent papules and nodules near the treatment area, at an early stage, superficial injections should be avoided.
To minimize the appearance of papules and nodules, the treated area should be massaged so that the product is evenly distributed.
Each vial is for single use (single patient and single session).
Reprocessing is prohibited.
AFTERCARE
Massage the treated area for 5 minutes, 5 times a day, for 5 days — and until two weeks after your final session.
ADVERSE EVENTS
As with any injectable, side effects can occur. Your specialist will walk you through the safety requirements and precautions. Report an adverse event via the link in the footer.